Xueyan Zhou

879 total citations
43 papers, 513 citations indexed

About

Xueyan Zhou is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xueyan Zhou has authored 43 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Physiology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xueyan Zhou's work include Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (10 papers) and MRI in cancer diagnosis (7 papers). Xueyan Zhou is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (10 papers) and MRI in cancer diagnosis (7 papers). Xueyan Zhou collaborates with scholars based in United States, China and Australia. Xueyan Zhou's co-authors include Tao Ma, Wenzhong Yang, Helena R. Zimmermann, C. Dirk Keene, Alexey G. Ryazanov, Nicole P. Kasica, Eric Klann, Douglas R. Cavener, Cristina M. Furdui and Jingyun Lee and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Xueyan Zhou

42 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueyan Zhou United States 14 283 176 95 61 55 43 513
Celia Fernandez United States 7 238 0.8× 228 1.3× 125 1.3× 56 0.9× 98 1.8× 7 482
Yuko Saito Japan 13 319 1.1× 131 0.7× 70 0.7× 36 0.6× 75 1.4× 41 514
Cathrin Schnack Germany 12 272 1.0× 279 1.6× 76 0.8× 38 0.6× 147 2.7× 15 671
Kanta Yanagida Japan 14 421 1.5× 282 1.6× 121 1.3× 116 1.9× 25 0.5× 28 762
Kazumi Motoki Japan 12 230 0.8× 180 1.0× 87 0.9× 76 1.2× 115 2.1× 16 547
Brandon C. Farmer United States 8 249 0.9× 220 1.3× 58 0.6× 37 0.6× 77 1.4× 9 491
Shiyong Diao United States 11 351 1.2× 218 1.2× 61 0.6× 51 0.8× 45 0.8× 11 604
Helen K. Warwick United Kingdom 4 218 0.8× 249 1.4× 138 1.5× 55 0.9× 89 1.6× 5 477
Changyi Ji United States 13 307 1.1× 254 1.4× 117 1.2× 80 1.3× 88 1.6× 23 689
Shelby E. Meier United States 9 223 0.8× 194 1.1× 78 0.8× 93 1.5× 65 1.2× 12 441

Countries citing papers authored by Xueyan Zhou

Since Specialization
Citations

This map shows the geographic impact of Xueyan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyan Zhou more than expected).

Fields of papers citing papers by Xueyan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyan Zhou. The network helps show where Xueyan Zhou may publish in the future.

Co-authorship network of co-authors of Xueyan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyan Zhou. A scholar is included among the top collaborators of Xueyan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyan Zhou. Xueyan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Qian, Yankai Zhang, Xueyan Zhou, et al.. (2025). Overactive Neuronal eEF2K/eEF2 signaling is associated with cognitive impairment and apathy-like behavior. Molecular Psychiatry.
2.
Yu, Xiaochen, Ke Sheng, Tong Fu, et al.. (2025). Apolipoprotein B100 acts as a tumor suppressor in ovarian cancer via lipid/ER stress axis-induced blockade of autophagy. Acta Pharmacologica Sinica. 46(5). 1445–1461. 2 indexed citations
3.
Yang, Qian, et al.. (2024). Suppression of neuronal AMPKβ2 isoform impairs recognition memory and synaptic plasticity. Neurobiology of Disease. 201. 106664–106664. 5 indexed citations
4.
Yang, Qian, Xueyan Zhou, & Tao Ma. (2024). Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer’s disease. Neurobiology of Aging. 140. 116–121. 1 indexed citations
5.
Zhou, Xueyan, Wenzhong Yang, Xin Wang, & Tao Ma. (2023). Isoform-specific effects of neuronal repression of the AMPK catalytic subunit on cognitive function in aged mice. Aging. 15(4). 932–946. 6 indexed citations
6.
Zhou, Xueyan, Xiaobing Fan, Aritrick Chatterjee, et al.. (2023). Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard tofts model in the diagnosis of prostate cancer. Physical and Engineering Sciences in Medicine. 46(3). 1215–1226. 1 indexed citations
7.
Kasica, Nicole P., et al.. (2022). Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer’s disease model mice independent of brain amyloid β pathology. Frontiers in Aging Neuroscience. 14. 959326–959326. 3 indexed citations
8.
Kasica, Nicole P., Xueyan Zhou, Qian Yang, et al.. (2021). Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer’s disease model mice. Journal of Neurochemistry. 160(5). 524–539. 13 indexed citations
9.
10.
Wang, Xin, Xueyan Zhou, Beth Uberseder, et al.. (2021). Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease. Neurobiology of Disease. 158. 105463–105463. 11 indexed citations
11.
Zhou, Yang, et al.. (2021). Histogram analysis based on multi-parameter MR imaging as a biomarker to predict lymph node metastasis in T3 stage rectal cancer. BMC Medical Imaging. 21(1). 176–176. 5 indexed citations
12.
Zhang, Ziqian, Xueyan Zhou, Yuning Zhang, et al.. (2020). Computational quantitative measures of Gd-EOB-DTPA enhanced MRI hepatobiliary phase images can predict microvascular invasion of small HCC. European Journal of Radiology. 133. 109361–109361. 8 indexed citations
13.
Zhou, Xueyan, Xiaobing Fan, Devkumar Mustafi, et al.. (2020). Comparison of DCE-MRI of murine model cancers with a low dose and high dose of contrast agent. Physica Medica. 81. 31–39. 3 indexed citations
14.
Yang, Wenzhong, Xueyan Zhou, Alexey G. Ryazanov, & Tao Ma. (2020). Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer’s disease. Neurobiology of Aging. 98. 225–230. 13 indexed citations
15.
Zhou, Xueyan, et al.. (2020). Repression of eEF2 kinase improves deficits in novel object recognition memory in aged mice. Neurobiology of Aging. 95. 154–160. 16 indexed citations
16.
Yang, Wenzhong, Xueyan Zhou, Helena R. Zimmermann, & Tao Ma. (2020). Brain-specific suppression of AMPKα2 isoform impairs cognition and hippocampal LTP by PERK-mediated eIF2α phosphorylation. Molecular Psychiatry. 26(6). 1880–1897. 29 indexed citations
17.
Yang, Wenzhong, Nicole P. Kasica, Helena R. Zimmermann, et al.. (2019). Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer’s disease model mice. Journal of Clinical Investigation. 129(2). 820–833. 62 indexed citations
18.
Zimmermann, Helena R., Wenzhong Yang, Nicole P. Kasica, et al.. (2018). Genetic removal of eIF2α kinase PERK in mice enables hippocampal L‐LTP independent of mTORC1 activity. Journal of Neurochemistry. 146(2). 133–144. 18 indexed citations
19.
Yang, Wenzhong, Xueyan Zhou, Helena R. Zimmermann, et al.. (2016). Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Neurobiology of Aging. 41. 19–24. 67 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celia Fernandez Breakdown of academic impact, for papers by Yuko Saito Breakdown of academic impact, for papers by Cathrin Schnack Breakdown of academic impact, for papers by Kanta Yanagida Breakdown of academic impact, for papers by Kazumi Motoki Breakdown of academic impact, for papers by Brandon C. Farmer Breakdown of academic impact, for papers by Shiyong Diao Breakdown of academic impact, for papers by Helen K. Warwick Breakdown of academic impact, for papers by Changyi Ji Breakdown of academic impact, for papers by Shelby E. Meier
Rankless by CCL
2026